VILGET

This brand name is authorized in Nigeria.

Active ingredients

The drug VILGET contains one active pharmaceutical ingredient (API):

1	Vildagliptin UNII I6B4B2U96P - VILDAGLIPTIN
	Vildagliptin enhances the sensitivity of beta cells to glucose, resulting in improved glucose-dependent insulin secretion by increasing the endogenous levels of these incretin hormones. The administration of vildagliptin results in a rapid and complete inhibition of DPP-4 activity, resulting in increased fasting and postprandial endogenous levels of the incretin hormones GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic polypeptide).
	Read more about Vildagliptin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-9698	Tablet	VILGET 50MG TABLET TAB 50 mg 3x10	130 RNW-PP-355363 VILGET 50MG TABLET VILDAGLIPTIN 50MG VILDAGLIPTIN 50MG B4-9698 Drugs Imported Products 310 POM 1 9/26/2023 GETZ PHARMA NIGERIA LIMITED, PLOT 2, IJAODOLA CLOSE, OFF ADEYEMO ALAKIJA STREET, IKEJA GRA, LAGOS. 8165370750 nneka.obegolu@getzpharma.com GETZ PHARMA (PRIVATE) LIMITED, 29 – 30/27, KORANGI INDUSTRIAL AREA,KARACHI-74900 PAKISTAN , Pakistan	21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BH02	Vildagliptin	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors
Discover more medicines within A10BH02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-9698